Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.

In adjusted analyses, B∗45-positive participants progressed 60 and 47% faster than negative participants, respectively, but was not associated with a significant trend toward faster clinical progression ( Table 2 ).

also in 9,775 other papers